articl
review
antitumor
antihiv
activ
natur
occur
triterpenoid
includ
lupan
ursan
oleanan
lanostan
dammaran
miscellan
scaffold
structureact
relationship
select
natur
compound
synthet
deriv
also
discuss
antitumor
agent
part
antiaid
agent
part
journal
natur
product
excel
reservoir
biolog
activ
compound
centuri
extract
natur
product
main
sourc
folk
medicin
even
today
mani
cultur
still
employ
directli
medicin
purpos
among
class
identifi
natur
product
triterpenoid
one
largest
famili
studi
intens
divers
structur
varieti
biolog
activ
continu
studi
natur
occur
drug
candid
review
describ
research
progress
last
three
year
triterpenoid
possess
cytotox
antihiv
activ
focu
occurr
biolog
activ
structureact
relationship
select
compound
synthet
deriv
betulin
acid
natur
occur
pentacycl
triterpen
belong
lupan
famili
present
mani
terrestri
plant
speci
eg
ancistrocladu
heyneanu
diospyro
leucomela
syzygium
formosanum
tetracera
boliviana
tryphyllum
peltatum
ziziphu
vulgari
compound
also
obtain
quantiti
bark
london
plane
tree
platanu
acerifolia
trumbul
cowork
identifi
inhibitori
activ
compound
tumor
promot
later
action
identifi
melanomaspecif
cytotox
mediat
induct
apoptosi
cytotox
well
mechan
action
review
although
initi
identifi
melanomaspecif
cytotox
agent
recent
studi
show
antiprolif
activ
cell
gi
well
neuroblastoma
skna
rhabdomyosarcomamedulloblastoma
breast
carcinoma
lung
carcinoma
colon
adenocarcinoma
multipl
myeloma
cervic
carcinoma
hpcc
glioblastoma
multiform
hpgbm
cell
line
ic
also
show
broadspectrum
cytotox
toward
lung
colorect
breast
prostat
cervic
cancer
cell
line
well
drugresist
colon
adenocarcinoma
cell
line
compound
induc
apoptosi
mitochondri
pathway
typic
decreas
cyclin
gene
express
increas
bax
gene
express
observ
sever
cancer
cell
line
treat
agre
prior
literatur
subsequ
studi
anticanc
mechan
reveal
potent
activ
chymotrypsinlik
activ
proteasom
addit
decreas
express
vascular
endotheli
growth
factor
vegf
antiapoptot
protein
survivin
prostat
cancer
cell
lncap
activ
select
proteasomedepend
degrad
transcript
factor
specif
protein
compound
also
inhibit
nfb
express
androgenrefractori
human
prostat
cancer
cell
exhibit
high
constitut
nfb
express
furthermor
although
reportedli
inhibitor
human
topoisomeras
topo
ii
show
synergist
effect
topoi
inhibitor
contrast
inhibit
format
topoi
dna
cleavabl
complex
apoptot
mediatora
induc
camptothecin
staurosporin
etoposid
prostat
cancer
cell
studi
also
indic
tumor
death
mediat
counteract
mitogenactiv
protein
kinas
inhibitor
melanoma
cell
structureact
relationship
sar
studi
led
prepar
numer
hydroxyl
doubl
bond
carboxyl
acid
miscellan
modifi
analogu
case
modif
led
alter
cytotox
potenc
select
reduct
doubl
bond
replac
carboxyl
group
ester
amid
side
chain
gener
gave
deriv
inact
cancer
cell
line
recent
approach
reveal
similar
result
compound
epim
demonstr
decreas
cytotox
compar
betulin
ester
exhibit
better
activ
kb
cell
deriv
potent
ic
cancer
cell
show
better
select
compar
healthi
cell
ic
monosaccharid
deriv
show
slightli
increas
cytotox
wherea
trisaccharid
analogu
inact
antihiv
studi
ad
side
chain
success
structur
modif
strategi
howev
result
potent
antihiv
lead
lost
abil
activ
chymotrypsinproteasom
activ
compar
acid
cddo
promis
anticanc
synthet
oleanol
acid
analogu
see
section
cddo
modif
concept
incorpor
are
triterpenoid
skeleton
also
appli
result
aringmodifi
deriv
also
evalu
addit
biolog
activ
reduc
activ
cholesterol
acyltransferas
format
triglycerid
tg
inhibit
diacylglycerol
acyltransferas
human
cell
studi
cardiovascular
activ
demonstr
upregul
eno
downregul
nadphoxidas
human
endotheli
cell
proinflammatori
effect
prove
block
interact
antibodi
classic
pathway
moreov
display
antiinflammatori
activ
suppress
gener
macrophag
ic
valu
respect
compound
also
competit
inhibitor
proteas
sarscov
highli
virul
coronaviru
k
valu
experi
variou
modifi
analogu
show
antimicrobi
activ
inhibitori
effect
toward
mycobacterium
tuberculosi
mic
trichophyton
soudanens
mic
mentagrophyt
mic
compound
also
inhibit
invas
porphyromoma
falciparum
erythrocyt
ic
valu
block
bind
effect
heatlabil
enterotoxin
lt
e
coli
intestin
epitheli
cell
result
suppress
ltinduc
diarrhea
lupeol
common
lupanetriterpen
wide
distribut
plant
kingdom
occur
across
multitud
taxonom
divers
genera
geograph
area
survey
chemic
abstract
databas
literatur
refer
period
report
occurr
lupeol
recent
publish
review
describ
chemoprevent
prospect
molecular
target
mechan
action
earlier
investig
apoptot
induct
cell
arrest
variou
cancer
cell
molecularlevel
phenomena
involv
mapk
death
receptor
nfb
signal
pathway
also
reveal
follow
vitro
vivo
studi
show
similar
result
inhibit
growth
lncap
cell
ic
significantli
reduc
testosteroneinduc
prostat
chang
mice
factor
compound
arrest
cell
cycl
g
phase
cell
phase
cell
xenograft
nude
mice
addit
caus
induct
elev
ratio
lncap
cell
observ
characterist
mitochondriamedi
apoptosi
interestingli
pretreat
posttreat
dose
mgmous
show
prevent
effect
respect
dmbainduc
dna
breakag
gum
resin
genu
boswellia
olibanum
frankincens
use
tradit
asia
africa
folk
medicin
treatment
arthriti
inflammatori
disord
main
activ
compon
resin
boswel
acid
ba
pentacycl
triterpen
carboxyl
acid
isol
variou
boswellia
speci
burseracea
includ
b
carterii
b
frereana
b
papyrifera
b
sacra
b
serrata
chemic
ba
differ
posit
two
methyl
group
ring
ba
substitut
ba
substitut
classifi
ursan
oleanan
group
triterpen
respect
rel
potenc
ba
propos
mechan
action
molecular
target
includ
nonredoxtyp
platelet
human
leukocyt
elastas
hle
cytochrom
enzym
cyp
topoisomeras
iia
nfb
kinas
ikk
b
review
inhibitori
effect
also
identifi
target
indic
antiinflammatori
hle
anticanc
topo
iiia
ikk
activ
ba
compound
commonli
known
akba
boswel
acid
well
explor
ba
recent
discoveri
reveal
show
moder
low
toxic
human
skinderiv
normal
cell
line
howev
induc
apoptosi
lncap
cell
death
receptor
mediat
pathway
signal
transduct
cascad
involv
activ
apoptosi
inhibitori
effect
signific
comparison
indomethacin
cyclophosphamid
bfgfinduc
angiogenesi
use
vivo
matrigel
plug
assay
two
acetyl
ba
deriv
show
almost
compar
activ
cisplatin
neuroblastoma
sknsh
cell
line
compound
trigger
apoptosi
activ
induct
dna
fragment
cell
xenotranspl
chick
chorioallanto
membran
compound
show
similar
inhibitori
effect
caroten
report
molar
ratio
respect
pm
tpa
use
inhibitor
tpamedi
ebvea
activ
assay
sever
antiinflammatori
studi
treatment
ba
b
serrata
diminish
chemicalor
stressinduc
edema
arthriti
gastric
ulcer
moder
low
activ
compound
demonstr
synergist
effect
combin
indomethacin
kainic
acidinduc
excitotox
oxid
damag
vitro
glucosamin
treatment
murin
edema
arthriti
antiinflammatori
assay
ba
gener
show
greater
potenc
ba
contrast
boswel
acid
ba
potent
analogu
ic
compar
deriv
purifi
topo
cytotox
sar
ba
seldom
address
recent
studi
show
higher
cytotox
activ
indic
import
acetyl
group
optim
potenc
ba
furthermor
ba
analogu
display
enhanc
cytotox
compar
correspond
ba
possess
acid
epim
amino
analogu
show
improv
activ
cddolik
see
section
analogu
show
enhanc
activ
cell
line
submicromolar
ec
valu
ec
ursol
acid
acid
preval
pentacycl
triterpenoid
carboxyl
acid
found
variou
plant
aglycon
glycosid
form
tradit
use
plant
contain
folk
medicin
abund
modern
studi
shown
possess
mani
biolog
activ
antioxid
antiinflammatori
antitumor
hepatoprotect
activ
divers
inflammatori
effect
review
ikeda
et
al
review
also
summar
inhibitori
activ
cancer
cell
may
due
suppress
inhibitor
nfb
pathway
phosphoryl
therebi
caus
downregul
express
downstream
oncogen
compound
may
also
reduc
skin
tumor
format
inhibit
bind
carcinogen
epiderm
dna
cell
membran
furthermor
induc
cell
differenti
apoptosi
certain
cancer
cell
line
detail
see
review
ikeda
et
al
current
work
provid
evid
bioactiv
inhibitori
effect
observ
mapk
pathway
associ
cell
apoptosi
endometri
cancer
cell
line
sngii
compound
exhibit
chemoprevent
effect
cancer
initi
phase
vivo
inhibitori
assay
aberr
crypt
foci
acf
put
precursor
colon
cancer
increas
neutral
sphingomyelinas
nsmase
activ
compound
also
inhibit
endogen
revers
transcriptas
rt
enzym
involv
control
cell
prolifer
differenti
melanoma
anaplast
carcinoma
aro
cell
line
downregul
express
two
cancerrel
gene
cmyc
aro
cell
stimul
contrast
reduc
amount
cell
growth
inhibit
induc
doxorubicin
result
might
due
scaveng
ro
involv
apoptot
process
induc
doxorubicin
similar
inhibitori
pattern
observ
h
induc
dna
breakag
cell
line
treat
sar
studi
compound
acetyl
moieti
hydroxi
group
show
greater
potenc
free
hydroxyl
addit
cddo
modif
strategi
appli
cyano
trifluoromethyl
deriv
acid
show
better
activ
iodoand
nonsubstitut
analogu
antiprolifer
assay
use
cancer
cell
line
ic
bioactiv
natur
occur
ursanetriterpen
also
report
topic
applic
asiat
acid
result
signific
reduct
skin
tumor
format
induc
tpa
tpainduc
h
thymidin
incorpor
lessen
concurr
inhibit
tpainduc
gener
express
ino
import
factor
tumor
promot
addit
induc
apoptosi
cancer
cell
apoptot
phenomena
includ
earli
activ
cell
cell
intracellular
releas
ca
observ
cell
line
cell
death
allevi
baptaam
intracellular
ca
inhibitor
result
impli
cell
death
attribut
ca
mediat
necrot
apoptosi
two
new
ursanetyp
triterpen
microfokienoxan
c
isol
leav
microtropi
fokienensi
glycyrrhizin
aglycon
glycyrrhet
acid
ga
abund
constitu
licoric
familiarli
speci
glycyrrhiza
glabra
aglycon
exist
effect
ga
inhibit
mutagen
induc
variou
mutagen
recent
review
pharmacolog
effect
glycyrrhiza
sp
describ
broadspectrum
bioactiv
includ
antiinflammatori
antivir
hepatoprotect
antitumor
immunomodulatori
detail
prior
studi
antitumor
activ
see
review
wang
nixon
asl
et
al
although
sever
studi
found
ga
demonstr
cytotox
apoptot
activ
result
shown
moder
low
potenc
thu
investig
focus
prepar
activ
deriv
chemosensit
activ
two
analogu
possess
alkoxyimino
group
carboxyl
acid
methyl
ester
show
slightli
stronger
antiprolif
apoptot
activ
gi
valu
improv
cell
howev
free
acid
import
methyl
ester
analogu
less
potent
apoptosi
assay
applic
cddo
modif
ga
success
methyl
cdodam
activ
cell
submicromolar
concentr
ec
anoth
studi
report
deriv
cytotox
ic
ic
ic
cell
ic
compar
rel
potenc
depend
cell
line
mechan
studi
reveal
potent
antitumor
activ
may
due
differenti
induct
two
tumorsuppressor
gene
colon
cancer
cell
subsequ
proapoptot
respons
also
induc
activ
kinas
kinaseindepend
inhibit
ar
psa
result
growth
inhibit
lncap
cell
compound
show
chemosensit
effect
variou
clinic
oncolog
drug
enhanc
sensit
vinblastin
cell
doxorubicin
kbmrp
cell
addit
partli
revers
multidrug
resist
pgpexpress
cell
multidrug
resist
protein
express
cell
kbmrp
increas
intracellular
accumul
antitumor
drug
interest
studi
chemic
conjug
paclitaxel
synthes
howev
although
conjug
compound
show
better
activ
still
less
potent
paclitaxel
base
find
like
glycyrrhet
acid
analogu
elicit
antitumor
activ
multipl
pathway
oleanol
acid
oa
well
known
triterpen
occur
numer
varieti
plant
possess
mani
biolog
properti
includ
antiinflammatori
trypanocid
antihiv
cytotox
activ
oa
report
suppress
tpainduc
tumor
promot
synthet
are
modifi
oa
analogu
improv
cytotox
pursu
acid
cddo
well
methyl
ester
cddome
design
synthes
honda
et
al
synthet
deriv
strongli
inhibit
product
induc
ifnin
mous
macrophag
ic
nm
derivat
cddo
yield
imidazolid
cddoim
amid
dinitril
dicddo
significantli
increas
antino
activ
among
deriv
cddoim
time
potent
cddo
ic
valu
pm
addit
strong
antiinflammatori
activ
cddo
deriv
report
exhibit
bioactiv
includ
cytoprotect
cancer
cell
growth
inhibit
apoptosi
induct
preliminari
studi
confirm
oa
potenti
becom
import
new
treatment
multipl
form
cancer
current
phase
clinic
trial
treatment
metastat
unresect
solid
tumor
lymphoma
pharmacolog
effect
induc
oarel
deriv
summar
recent
review
libi
et
al
sogno
et
al
sultana
et
al
xanifoliay
isol
xanthocera
sorbifolia
sever
hydrolyz
deriv
prepar
glycosid
angeloyl
group
cytotox
ic
cell
either
nonesterifi
glucosid
diesterifi
aglycon
ic
respect
thu
ester
moieti
requir
cytotox
hydrolysi
trisaccharid
slightli
lower
activ
maslin
acid
oleanan
triterpen
identifi
crataegu
oxyacantha
recent
also
isol
appl
peel
along
deriv
three
compound
evalu
antitumor
activ
togeth
show
minor
antiprolif
effect
ec
ec
ec
show
effect
cell
line
ec
compound
also
isol
quantit
oliv
fruit
show
weak
antiprolif
effect
cell
line
ec
without
necrot
effect
acid
amooranin
isol
stem
bark
amoora
rohituka
cytotox
cell
line
ic
delay
tumor
growth
rate
xenograft
nude
mice
concurr
microarray
studi
show
caus
downregul
vegf
jun
gene
associ
angiogenesi
antiprolifer
cancer
cell
respect
capilliposid
b
epoxyoleanan
saponin
isol
lysimachia
capillip
cytotox
human
cell
ic
valu
semisynthet
approach
ganoder
acid
isol
ganoderma
lucidum
assess
antiprolifer
activ
show
ic
valu
human
cervic
carcinoma
cell
hela
furthermor
hela
cell
arrest
phase
cell
cycl
apoptosi
simultan
proteom
studi
led
identif
gene
regul
proteinrel
gene
may
play
import
role
cytotox
ganoderiol
f
deriv
ganoderma
amboinens
found
inhibit
prolifer
cancer
cell
line
includ
chronic
myelogen
leukemia
ic
hepatocellular
carcinoma
ic
respect
activ
mapk
ekr
upregul
cdk
inhibitor
found
earli
stage
treatment
presum
caus
cellcycl
arrest
phase
trigger
prematur
senesc
cell
dehydrotrametenol
acid
lanostan
triterpen
isol
sclerotium
poria
coco
select
inhibit
hrastransform
cell
induc
apoptosi
pathway
cell
treat
arrest
phase
accumul
phase
high
gi
valu
compound
also
regul
express
hra
akt
erk
downstream
protein
hra
signal
pathway
addit
subsequ
studi
fungu
yield
lanostan
triterpen
show
inhibitori
effect
ebvea
activ
assay
raji
cell
compound
also
show
inhibitori
effect
dmbaand
tpamedi
vivo
murin
skin
test
impatiensid
bivittosid
two
lanostanetyp
triterpen
contain
hexasaccharid
moieti
isol
sea
cucumb
holothuria
impatien
two
glycosid
exhibit
vitro
cytotox
equal
slightli
better
clinic
antitumor
drug
etoposid
seven
differ
human
tumor
cell
includ
colon
cancer
lung
cancer
hepatoma
prostat
cancer
breast
cancer
nasopharyng
cancer
kb
ic
valu
cucurbitanetyp
triterpen
isom
lanostan
constitut
group
divers
substanc
known
bitter
toxic
isol
initi
cucurbitacea
plant
later
found
plant
famili
besid
cytotox
anticanc
activ
cucurbitacin
also
exhibit
wide
rang
vitro
vivo
pharmacolog
effect
purg
antiinflammatori
antifertil
howev
compound
limit
usag
due
nonspecif
toxic
distribut
structur
character
bioactiv
review
chen
et
al
recent
studi
show
cucurbitacin
b
possess
weak
inhibitori
effect
laryng
squamou
cell
carcinoma
ic
may
due
inhibit
transcript
activ
cell
growth
b
isol
root
trichosanth
kirilowii
inhibit
prolifer
human
breast
cancer
cell
ic
arrest
cell
cycl
g
phase
antiprolifer
activ
reduc
caspasefamili
inhibitor
zvadfmk
suggest
mitochondriadepend
pathway
cucurbitacin
j
elicit
antiprolif
effect
hepatocellular
carcinoma
cell
ic
respect
malign
melanoma
cell
ic
respect
ginsenosid
seri
compound
compris
triterpen
relat
glycosid
isol
leav
stem
berri
root
differ
panax
speci
recent
ginsenosid
natur
resourc
evalu
antitumor
activ
howev
compar
triterpen
ginsenosid
show
low
cytotox
ic
variou
cancer
cell
line
antiangiogen
properti
protopanaxadiol
protopanaxatriol
evalu
vitro
angiogenesi
assay
use
huvec
compound
demonstr
strong
antiprolif
activ
ec
furthermor
induc
apoptosi
cell
cycl
arrest
phase
inhibit
prolifer
hpac
cell
line
ic
respect
potent
addit
three
semisynthet
deriv
sugar
moieti
show
signific
cytotox
mcf
cancer
cell
line
see
tabl
howev
due
complex
structur
limit
extent
studi
sar
conclus
could
readili
establish
dichapetalintyp
triterpenoid
quinonoid
triterpenescelastrol
quinon
methid
triterpenoid
isol
recent
celastru
orbiculatu
cheiloclinium
cognatum
maytenu
chuchuhuasca
alreadi
known
celastrol
exhibit
antiinflammatori
antioxid
neuroprotect
antiinfect
properti
strong
cytotox
effect
report
earli
recent
studi
show
cytotox
pancreat
cancer
cell
ic
vitro
activ
xenograft
vivo
mice
inhibit
tumor
metastasi
transgen
mous
model
pancreat
islet
carcinoma
previou
investig
strong
antitumor
effect
prompt
seri
studi
molecular
target
enhanc
cytotox
effect
tnf
paclitaxel
doxorubicin
well
tnfb
pathway
nfbregul
gene
product
pharmacolog
studi
show
inhibit
activ
nfb
block
phosphoryl
degrad
ikb
kinas
upstream
nfb
signal
transduct
cascad
gedunin
found
inhibit
function
act
outsid
atpbind
pocket
similar
action
exist
drug
cisplatin
novobiocin
concurr
studi
reveal
suppress
activ
aryl
hydrocarbon
receptordepend
gene
express
oral
leukoplakia
cell
implic
chemoprevent
effect
investig
antiangiogenesi
effect
reveal
suppress
angiogenesi
act
vegf
tyrosin
kinas
receptor
vegf
compound
also
show
vitro
vivo
chymotrypsinlik
proteasom
inhibitori
activ
toward
purifi
proteasom
proteasom
ic
lncap
cell
inhibit
xenograft
tumor
nude
mice
subsequ
sar
studi
semisynthet
analogu
conclud
quinon
methid
moieti
import
cytotox
activ
dihydrocelastrol
deriv
aromat
quinon
methid
moieti
inact
cytotox
antitubulin
polymer
assay
free
acid
present
requir
abil
induc
apoptosi
ester
amid
deriv
show
equal
lower
potenc
inhibit
growth
human
mous
melanoma
tumor
cell
analogu
lack
tingenon
show
lower
activ
vitro
tubulin
polymer
inhibit
cytotox
assay
cell
line
tetranortriterpen
limonoid
triterpenoid
belong
limonoid
famili
occur
glucosid
aglycon
fruit
rutacea
meliacea
plant
famili
show
put
antitumor
properti
suffici
review
regard
distribut
biosynthet
pathway
bioactiv
latest
studi
antiprolif
effect
three
limonoid
limonin
nomilin
obacunon
confirm
either
aglycon
glycosid
compound
exert
versatil
action
neuroblastoma
cancer
cell
induc
apoptosi
arrest
cancer
cell
cycl
phase
show
aneuploid
effect
elev
aneuploid
number
treat
cancer
cell
compar
untreat
one
aglycon
glucosid
toxic
cell
aglycon
less
effect
caus
rapid
cell
death
dideacetylkhivorin
isol
khaya
senegalensi
subsequ
cytotox
screen
show
activ
siha
ic
ic
ic
cancer
cell
line
nimbolid
gedunin
limonoid
antimalari
insecticid
antitumor
activ
recent
isol
xylocarpu
granatum
cedrela
sinensi
exert
weak
antitumor
activ
cell
line
ic
valu
howev
deriv
show
moder
cytotox
murin
leukemia
cell
ic
valu
rang
studi
exhibit
weak
activ
ic
suggest
oxygen
function
posit
critic
modif
gave
two
activ
analogu
carbam
keton
group
compound
demonstr
antiprolif
activ
compar
act
modul
heat
shock
protein
cell
methyl
angolens
natur
tetranortriterpenoid
deriv
root
callu
soymida
febrifuga
possess
low
cytotox
activ
ic
induc
apoptosi
trigger
intrins
pathway
quassinoidsquassinoid
bitter
constitu
secondari
metabolit
exclus
simaroubac
origin
regard
biogenet
degrad
triterpenoid
quassinoid
divers
bioactiv
includ
antifeed
insecticid
herbicid
antiparasit
antimalari
antitumor
effect
earli
report
ascrib
wide
rang
antitumor
activ
bruceantin
quassinoid
triterpen
elicit
major
interest
quassinoid
promis
lead
drug
howev
complex
chemic
structur
quassinoid
limit
anticanc
potenti
detail
see
review
vieira
et
al
tigloyloxychaparrinon
isol
ailanthu
integrifolia
antitumor
activ
report
recent
studi
led
isol
altissima
show
inhibitori
effect
hypoxiainduc
vegf
erythropoietin
express
activ
transcript
factor
protein
promot
tumor
cell
adapt
surviv
hypox
condit
brusatol
show
cytotox
activ
murin
cancer
cell
ic
valu
are
modifi
compound
show
reduc
activ
indic
enol
oxygen
essenti
activ
analogu
show
even
weaker
activ
indic
hydroxi
group
also
import
chemosensit
studi
potenti
cytotox
antitumor
drug
colchicin
vinblastin
paclitaxel
mdr
nasopharyng
cancer
cell
line
inhibit
pgp
mediat
drug
efflux
jaspolid
b
novel
isomalabaricanetyp
triterpen
isol
marin
spong
jaspi
spp
exhibit
cytotox
toward
hepatoma
ic
ic
human
promyeloleukem
ic
cell
line
subsequ
studi
show
induc
apoptosi
cell
cycl
arrest
phase
phase
author
natur
product
research
laboratori
first
discov
betulin
acid
ba
show
inhibitori
effect
iiib
replic
ec
valu
sinc
betulin
acid
use
preemin
molecular
scaffold
develop
triterpen
analogu
antihiv
drug
systemat
structur
modif
carri
hydroxyl
are
isopropenyl
group
carboxyl
moieti
led
discoveri
mani
potent
antihiv
agent
tabl
hydroxi
group
readili
acyl
wide
varieti
anhydrid
acid
chlorid
modif
result
ultim
identif
bevirimat
ba
display
signific
antihiv
ec
valu
nm
sar
studi
also
show
ester
function
appropri
length
side
chain
termin
carboxyl
acid
moieti
dimethyl
substitut
posit
critic
enhanc
antivir
potenc
sar
demonstr
within
dimethyl
moieti
smethyl
contribut
toward
activ
smonomethylsuccinylsubstitut
ba
smsb
show
similar
antivir
potenc
ec
nm
respect
rmsb
show
much
reduc
activ
ec
mechan
action
studi
reveal
retain
nanomolar
antivir
potenc
isol
resist
revers
transcriptas
rt
proteas
pr
inhibitor
defin
target
bevirimat
scientist
panaco
pharmaceut
inc
nation
institut
health
character
viru
produc
cell
treat
compound
studi
show
inhibit
process
viral
gag
polyprotein
specif
step
convers
capsid
precursor
matur
capsid
ca
dosedepend
manner
impair
cleavag
led
product
morpholog
defect
noninfecti
immatur
viral
particl
fig
therefor
design
amatur
inhibitor
mi
new
class
antiretrovir
famili
current
phase
iib
clinic
trial
enter
phase
iii
clinic
trial
convers
aminoalkano
acid
deriv
discov
function
block
viral
entri
host
cell
increment
chain
lengthen
significantli
influenc
antihiv
potenc
deriv
introduct
second
aminoalkano
acid
end
side
chain
could
modul
antivir
potenc
research
led
discoveri
statin
deriv
inhibit
infect
sever
strain
ec
valu
rang
stereoisom
show
equipot
antivir
test
design
slightli
simplifi
substitu
also
show
similar
antihiv
activ
compar
mechan
action
studi
discov
ba
analogu
function
postbind
step
necessari
viru
entri
host
cell
detail
studi
found
induc
nonproduct
conform
abl
trigger
conform
rearrang
membran
fusion
evid
also
indic
target
loop
domain
involv
chemokin
receptor
bind
exact
bind
target
triterpen
deriv
still
investig
modif
isopropenyl
group
show
littl
effect
antihiv
activ
neither
satur
doubl
bond
allyl
substitut
ether
thioether
linkag
influenc
antihiv
activ
deriv
significantli
research
demonstr
posit
serv
good
place
incorpor
watersolubil
moieti
increas
hydrophil
compound
class
interestingli
indic
target
triterpen
analogu
vari
depend
side
chain
modif
posit
analogu
potent
hiv
entri
inhibitor
deriv
function
block
viru
matur
combin
two
modif
led
identif
bifunct
hiv
inhibitor
interfer
viral
entri
matur
compound
secondari
amin
form
amid
bond
exhibit
significantli
increas
metabol
stabil
pool
human
liver
microsom
compound
show
potent
antihiv
activ
slightli
better
gerrish
et
al
synthes
anoth
seri
compound
contain
dimethylsuccinyl
ester
side
chain
various
substitut
benzyl
phenethyl
amid
sever
compound
seri
show
potent
antihiv
activ
show
best
pharmacokinet
pharmacodynam
pkpd
properti
gener
substitut
orthoposit
benzyl
phenyl
ring
provid
best
activ
deriv
may
serv
attract
promis
lead
develop
next
gener
inhibitor
clinic
trial
candid
hydroxylnorlupa
acid
lupanelik
triterpen
rearrang
fivememb
are
isol
thorn
gleditsia
sinensi
show
signific
antihiv
activ
ec
valu
fact
differ
are
configur
suggest
are
function
import
pharmacophor
antivir
activ
lupanetyp
triterpen
new
triterpen
acid
obtain
search
antivir
agent
stem
stauntonia
obovatifoliola
compound
exhibit
good
proteas
activ
ec
compar
control
ec
known
proteas
inhibitor
result
suggest
seco
are
dual
polar
moieti
may
increas
antivir
proteas
activ
triterpen
concurr
studi
lupan
oleananetyp
triterpen
show
similar
antihiv
proteas
activ
test
analyz
structur
care
discov
oh
group
import
enhanc
antivir
potenc
lupan
triterpen
seen
compound
oleananetyp
triterpen
maslin
acid
inhibit
proteas
order
explor
antivir
activ
sever
differ
amino
acid
singl
dipeptid
tripeptid
coupl
posit
use
solutionand
solidphas
synthet
method
howev
compound
acid
conjug
dipeptid
lvalin
show
approxim
inhibit
activ
viru
replic
deriv
show
cytotox
although
display
cytotox
antivir
activ
prior
research
glycyrrhet
acid
synthet
deriv
mainli
led
neg
result
modif
focus
substitut
hydroxi
carboxyl
acid
group
rigid
triterpen
scaffold
determin
rel
posit
function
side
chain
skeleton
could
import
antihiv
bioactiv
therefor
distanc
hydroxi
group
carboxyl
moieti
dihedr
angl
de
ring
predict
use
model
softwar
result
provid
possibl
explan
analogu
show
fewer
antihiv
effect
analogu
betulin
moron
acid
recent
paper
report
synthesi
antihiv
activ
group
analogu
dglucosamineconjug
glycyrrhet
acid
glucosamin
link
group
spacer
contain
phthalic
maleic
succin
acid
residu
although
modif
slightli
increas
antihiv
activ
antivir
potenc
deriv
remain
moder
potent
analogu
carbamoyl
acid
antihiv
ec
valu
antihiv
biolog
activ
oleanol
acid
oa
deriv
review
sultana
et
al
basic
oa
identifi
antihiv
principl
inhibit
replic
ec
valu
therapeut
index
ti
modif
oa
posit
led
discoveri
dimethylsuccinyloa
signific
antivir
ec
nm
ti
valu
howev
due
differ
screen
system
report
activ
may
vari
differ
public
mechan
action
similar
function
matur
inhibitor
block
cleavag
result
product
morpholog
defect
noninfecti
hiv
particl
sar
oa
differ
succinyl
glutaryl
substitut
show
similar
trend
compar
ba
analogu
suggest
side
chain
import
pharmacophor
triterpen
backbon
may
serv
docker
allow
side
chain
interact
target
previous
optim
side
chain
identifi
bifunct
betulin
acid
ba
analogu
therefor
extend
research
focu
replac
triterpenoid
docker
oa
deriv
also
prepar
compound
oa
deriv
link
posit
dimethylsuccinyl
link
posit
show
antihiv
activ
ec
valu
activ
lower
ident
substitut
ba
analogu
ec
indic
ba
betterfit
docker
oa
moron
acid
isol
brazilian
propoli
herbal
medicin
use
worldwid
exhibit
signific
antihiv
activ
ec
valu
ti
author
group
report
discoveri
seri
deriv
exhibit
remark
antihiv
potenc
compound
contain
substitut
differ
amid
side
chain
exhibit
potent
antihiv
activ
lymphocyt
ec
valu
respect
tabl
activ
result
similar
ec
drug
candid
current
phase
iib
antiaid
clinic
trial
anoth
deriv
synthes
antivir
ec
valu
tabl
mechan
action
studi
reveal
betulin
acid
moron
acid
analogu
exhibit
antifus
antimatur
activ
thu
design
bifunct
triterpen
sar
discov
longer
side
chain
help
enhanc
antivir
potenc
anoth
oleananetyp
triterpen
papyriogenin
isol
flower
pith
leav
fruit
tetrapanax
papyriferu
show
antivir
activ
ec
valu
less
lymphocyt
ursol
acid
ua
well
ua
analogu
synthes
evalu
antihiv
activ
tabl
dimethylglutaryl
substitut
deriv
ua
exhibit
antihiv
replic
ec
valu
respect
compound
evalu
differ
assay
system
also
display
antihiv
activ
ec
valu
activ
triterpen
side
chain
differ
scaffold
compar
discov
among
synthes
compound
effect
molecular
scaffold
antihiv
activ
remain
betulin
acid
ec
valu
mm
follow
moron
ursol
oleanol
acid
addit
aaminophosphon
conjug
ua
howev
result
analogu
show
zerotoweak
antihiv
entri
activ
best
compound
inhibit
viral
entri
concentr
result
prove
conclus
longer
side
chain
import
triterpenederiv
hiv
entri
inhibitor
carbon
chain
length
optim
plant
genu
schisandra
known
contain
dibenzocycloctadien
lignan
well
lanostan
cycloartan
triterpen
sun
group
began
phytochem
studi
sever
speci
schisandra
genu
collect
yunnan
provinc
china
led
discoveri
seri
norcycloartan
triterpenoid
sun
group
also
identifi
sever
nortriterpenoid
bisnortriterpenoid
variou
speci
schisandra
possess
weak
moder
activ
rubriflordilacton
b
isol
leav
stem
schisandra
rubriflora
rubriflorin
ac
three
highli
oxygen
nortriterpenoid
also
isol
leav
stem
schisandra
rubriflora
featur
open
are
found
plant
shortli
discoveri
also
contain
open
are
show
moder
weak
antihiv
activ
ec
valu
rang
sphenadilacton
b
isol
leav
stem
schisandra
sphenanthera
structur
elucid
accomplish
extens
nmr
singlecryst
xray
crystallographi
howev
erratum
later
publish
correct
stereochemistri
rather
orient
compound
exhibit
weak
activ
ec
iiib
infect
cell
obviou
cytotox
observ
compound
test
three
human
tumor
cell
line
minor
nortriterpenoid
sphenadilacton
c
also
isol
subsequ
studi
schisandra
sphenanthera
character
presenc
partial
enol
structur
first
exampl
acetamidebear
highli
oxygen
nortriterpenoid
cycloartan
compound
also
exhibit
weak
antivir
activ
iiib
ec
genu
kadsura
belong
famili
schisandracea
investig
kadsura
heteroclita
new
nortriterpenoid
longipedlacton
j
isol
test
iiib
infect
cell
show
moder
antihiv
ec
four
new
lanostan
triterpen
colossolacton
v
vi
vii
viii
isol
fruit
bodi
vietnames
mushroom
ganoderma
colossum
seco
aand
ere
differ
structur
previou
isol
colossolacton
sevenmemb
lacton
are
sixmemb
lacton
ere
compound
lacton
ere
seco
are
compound
aand
elacton
ring
three
new
triterpenoid
togeth
three
previous
isol
compound
collosolacton
e
schisanlacton
colossolacton
g
test
proteas
compound
show
antiproteas
activ
ec
valu
respect
inact
presenc
hydroxi
group
r
r
test
compound
reduc
activ
ie
vs
vs
suggest
hydrophob
triterpen
skeleton
import
proteas
inhibit
activ
are
seco
compound
singl
doubl
bond
exhibit
higher
activ
relat
two
doubl
bond
unsatur
pattern
would
alter
threedimension
structur
consequ
spatial
arrang
pharmacophor
compound
signific
influenc
activ
hand
presenc
seco
lacton
aandor
ere
significantli
influenc
antihiv
proteas
activ
analogu
two
unusu
octanorcucurbitacin
endecaphyllacin
b
isol
tuber
hemsleya
endecaphylla
two
compound
togeth
three
known
cucurbitan
analogu
includ
cucurbitacin
evalu
abil
prevent
cytopath
effect
cell
although
compound
show
moder
antihiv
activ
ec
show
signific
potenc
ec
respect
assay
high
activ
may
due
presenc
function
side
chain
howev
first
report
common
cucurbitan
analogu
potent
antivir
activ
repeat
evalu
may
necessari
confirm
compound
potenc
kuguacin
ae
isol
root
momordica
charantia
also
belong
cucurbitacin
famili
mechan
action
studi
reveal
block
transmiss
viru
celltocel
fusion
inhibit
activ
rt
pr
zinc
eject
viral
replic
chronic
infect
lymphocyt
thu
like
function
entri
inhibitor
compound
togeth
acutissimatriterpen
c
isol
phyllanthu
acutissima
activ
newli
discov
compound
test
use
cellbas
antivir
replic
assay
revers
transcriptas
rt
assay
compound
exhibit
moder
antivir
replic
activ
ec
valu
respect
show
weak
antihiv
activ
interestingli
inhibit
rt
test
concentr
show
inhibit
rt
comparison
compound
inhibit
rt
suggest
rt
may
compound
target
activ
mechan
action
triterpenoid
isol
alnu
firma
review
yu
et
al
among
alnust
acid
methyl
ester
exhibit
antihiv
proteas
activ
ec
valu
similar
compound
show
effect
rt
proteas
two
hopan
triterpen
dryopter
acid
b
isol
rhizom
dryopteri
crassirhizoma
aspidiacea
test
recombin
proteas
pr
compound
exhibit
moder
antihiv
proteas
activ
ec
valu
respect
comparison
ursol
acid
ec
acetyl
hydroxi
group
yield
compound
show
enhanc
antiproteas
activ
compar
parent
compound
result
suggest
carboxyl
group
posit
acetyl
group
posit
could
play
key
role
inhibit
proteas
hopan
seri
triterpen
acid
triterpenoid
import
group
biolog
activ
natur
compound
particularli
approxim
new
triterpenoid
identifi
year
sinc
connolli
hill
regularli
review
scientif
literatur
deal
triterpenoid
character
natur
resourc
although
numer
triterpenoid
possess
variou
scaffold
report
small
portion
explor
systemat
pharmacolog
activ
explor
show
margin
potenc
preliminari
screen
howev
fact
mean
elimin
investig
instanc
betulin
acid
exhibit
moder
antihiv
activ
ec
modif
furnish
clinic
trial
agent
bevirimat
soon
phase
iii
antihiv
drug
anoth
exampl
cddo
promis
anticanc
candid
phase
clinic
trial
deriv
oleanol
acid
weak
antitumor
compound
gener
speak
bioactivitydirect
fraction
isol
bdfi
major
approach
new
lead
gener
follow
lead
optim
base
ration
drug
design
synthesi
bioevalu
well
structureact
relationship
sar
quantitativesar
qsar
studi
select
preclin
candid
also
involv
rapid
effici
assay
gather
absorpt
distribut
metabol
excret
toxic
admet
data
permit
effect
evalu
drug
candid
earli
stage
drug
discoveri
process
although
still
concern
especi
regard
structur
complex
nonspecif
pharmacolog
effect
natur
occur
bioactiv
triterpenoid
divers
uniqu
make
worthi
pursuit
discoveri
new
drug
simplifi
apoptot
signal
scheme
modul
akba
ref
posit
upregulatori
effect
akba
neg
inhibitori
effect
ikk
target
direct
inhibit
akba
postul
ne
effect
bevirimat
target
gag
cleavag
site
interfer
process
matur
result
product
morpholog
defect
noninfecti
viral
particl
panaco
xvii
intern
hiv
drug
resist
workshop
spain
